Brad Jones - Search Results

Year	Number of Results
2002	1
2004	1
2005	1
2006	7
2007	1
2008	7
2009	5
2010	5
2011	8
2012	10
2013	3
2014	2
2015	5
2016	7
2017	3
2018	13
2019	11
2020	18
2021	14
2022	0

1

SARS-CoV-2-specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein.

Keller MD, Harris KM, Jensen-Wachspress MA, Kankate VV, Lang H, Lazarski CA, Durkee-Shock J, Lee PH, Chaudhry K, Webber K, Datar A, Terpilowski M, Reynolds EK, Stevenson EM, Val S, Shancer Z, Zhang N, Ulrey R, Ekanem U, Stanojevic M, Geiger A, Liang H, Hoq F, Abraham AA, Hanley PJ, Cruz CR, Ferrer K, Dropulic L, Gangler K, Burbelo PD, Jones RB, Cohen JI, Bollard CM. Keller MD, et al. Among authors: jones rb. Blood. 2020 Dec 17;136(25):2905-2917. doi: 10.1182/blood.2020008488. Blood. 2020. PMID: 33331927 Free PMC article.

2

Immunological approaches to HIV cure.

Ward AR, Mota TM, Jones RB. Ward AR, et al. Among authors: jones rb. Semin Immunol. 2021 Jan;51:101412. doi: 10.1016/j.smim.2020.101412. Epub 2020 Sep 24. Semin Immunol. 2021. PMID: 32981836 Free article. Review.

3

In Vitro and In Vivo Models of HIV Latency.

Whitney JB, Brad Jones R. Whitney JB, et al. Among authors: brad jones r. Adv Exp Med Biol. 2018;1075:241-263. doi: 10.1007/978-981-13-0484-2_10. Adv Exp Med Biol. 2018. PMID: 30030796 Review.

4

Roles of fragment crystallizable-mediated effector functions in broadly neutralizing antibody activity against HIV.

Danesh A, Ren Y, Brad Jones R. Danesh A, et al. Among authors: brad jones r. Curr Opin HIV AIDS. 2020 Sep;15(5):316-323. doi: 10.1097/COH.0000000000000644. Curr Opin HIV AIDS. 2020. PMID: 32732552 Free PMC article. Review.

5

HIV-specific CD8⁺ T cells and HIV eradication.

Jones RB, Walker BD. Jones RB, et al. J Clin Invest. 2016 Feb;126(2):455-63. doi: 10.1172/JCI80566. Epub 2016 Jan 5. J Clin Invest. 2016. PMID: 26731469 Free PMC article. Review.

6

Editorial: On two fronts: synergies and costs at the interface of responses to two global viral pandemics.

Jones RB. Jones RB. Curr Opin HIV AIDS. 2021 Jan;16(1):1-2. doi: 10.1097/COH.0000000000000662. Curr Opin HIV AIDS. 2021. PMID: 33278159 No abstract available.

7

T-cell therapies for HIV: Preclinical successes and current clinical strategies.

Patel S, Jones RB, Nixon DF, Bollard CM. Patel S, et al. Among authors: jones rb. Cytotherapy. 2016 Aug;18(8):931-942. doi: 10.1016/j.jcyt.2016.04.007. Epub 2016 Jun 2. Cytotherapy. 2016. PMID: 27265874 Free PMC article. Review.

8

Diverse Impacts of HIV Latency-Reversing Agents on CD8+ T-Cell Function: Implications for HIV Cure.

Clutton GT, Jones RB. Clutton GT, et al. Among authors: jones rb. Front Immunol. 2018 Jun 22;9:1452. doi: 10.3389/fimmu.2018.01452. eCollection 2018. Front Immunol. 2018. PMID: 29988382 Free PMC article. Review.

9

Challenges and Opportunities for T-Cell-Mediated Strategies to Eliminate HIV Reservoirs.

Brockman MA, Jones RB, Brumme ZL. Brockman MA, et al. Among authors: jones rb. Front Immunol. 2015 Oct 2;6:506. doi: 10.3389/fimmu.2015.00506. eCollection 2015. Front Immunol. 2015. PMID: 26483795 Free PMC article. Review.

10

Selectively Depolymerizable Polyurethanes from Unsaturated Polyols Cleavable by Olefin Metathesis.

Jones BH, Staiger C, Powers J, Herman JA, Román-Kustas J. Jones BH, et al. Macromol Rapid Commun. 2021 Feb;42(4):e2000571. doi: 10.1002/marc.202000571. Epub 2020 Dec 9. Macromol Rapid Commun. 2021. PMID: 33300207

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results